Examples of using Primary endpoint in English and their translations into Russian
{-}
-
Official
-
Colloquial
The primary endpoint was all-cause mortality.
Parameters for measuring the success of treatment=> primary Endpoints.
The primary endpoint was repeat AF ablation.
Incidences of individual elements of the primary endpoint also were assessed separately.
The primary endpoint was MACE at 12-month follow-up.
Major bleeding(BARC≥ 3b) at 48 hours after TAVR or at discharge,the first co-primary endpoint, was observed in 28 patients(6.9%) in the bivalirudin arm and 36 patients(9%) in the heparin arm RR 0.77; 95% CI.
The primary endpoints of each trial were hair count and user self-assessment.
At the median follow-up point of 643 days(interquartile range, 575-758 days),the composite primary endpoint occurred in 345 patients(26%) treated with ranolazine and 364 patients(28%) treated with placebo HR 0.95; 95% CI, 0.82-1.1.
The primary endpoint of the study was a 6-month progression-free survival PFS.
The primary endpoints were recurrent ACS or a composite event of CAD-related death or recurrent ACS.
The primary endpoint was incidence of graft failure and secondary endpoints were GVHD and survival.
The primary endpoint was the total number of days of hospitalization within 60 days after randomization.
The primary endpoint was a composite of survival, worsening HF and patient global evaluation at 24 weeks.
The primary endpoint was incidence of graft failure and secondary endpoints were GVHD and survival.
The primary endpoint was cardiomyopathy diagnosed 5 months after delivery to end of follow-up period, nearly 35 years later.
The primary endpoint was the incidence of stroke or systemic embolism(SE) during a mean follow-up of 24.9 months.
The primary endpoint was recurrence of AF or atrial tachycardia during follow-up, without treatment with antiarrhythmic medication.
Primary endpoint: obtaining an opinion on the results of the multidisciplinary expertise for each case of multi-stage treatment.
The primary endpoint was major adverse CV events, defined as CV death, MI, stroke or coronary revascularization.
The primary endpoint was time to first occurrence of ischemia-driven revascularization or ischemia-driven hospitalization without revascularization.
The study's two primary endpoints, which were assessed at 4 months on MRI, were LVEF and left ventricular end diastolic function LVEDF.
The primary endpoint is major bleeding and secondary endpoints include minor bleeding, stroke, systemic embolism and transient ischemic attack.
In the primary endpoint of the trial, a statistically significant proportion of patients receiving vedolizumab SC beginning at week 6 and every two weeks following achieved clinical remission** at week 52 compared to placebo.
Co-primary endpoints included BARC major bleeding of at least grade 3b at 48 hours after TAVR or at hospital discharge, whichever occurred first, and net clinical adverse events(death, MI, stroke and major bleeding) for up to 30 days.
The primary efficacy endpoint is time to death, MI, stroke or systemic embolism and the primary safety endpoint is time to first major bleeding event.
The primary efficacy endpoints were changes from the pre-MRI/waiting period to 1 months in ventricular pacing capture threshold and ventricular sensed amplitude.
The primary GI and cardiovascular endpoints were composite upper GI events and major adverse cardiac events(MACE).
The study's primary safety endpoints was procedure- and device-related adverse events and postprocedure CV or vascular complications, decrement in renal function or renal artery abnormality on angiographic follow-up at 6 months.
The primary factor driving the different conclusions is the decision on which health endpoints to include, a decision based on uncertainty in the physical and health sciences.
In practice, however,it is usually desirable that all endpoints of a gateway are controlled by the same call agent; other call agents are available to provide redundancy in the event that the primary call agent fails, or loses contact with the media gateway.